| 000 | 00969 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516122202.0 | ||
| 264 | 0 | _c20130523 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1759-4782 | ||
| 024 | 7 |
_a10.1038/nrclinonc.2012.201 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMitin, Timur | |
| 245 | 0 | 0 |
_aUrological cancer. The benefits of intermittent androgen-deprivation therapy. _h[electronic resource] |
| 260 |
_bNature reviews. Clinical oncology _cDec 2012 |
||
| 300 |
_a672-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 700 | 1 | _aEfstathiou, Jason A | |
| 700 | 1 | _aShipley, William U | |
| 773 | 0 |
_tNature reviews. Clinical oncology _gvol. 9 _gno. 12 _gp. 672-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrclinonc.2012.201 _zAvailable from publisher's website |
| 999 |
_c22276695 _d22276695 |
||